TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/21 18:44 | 4/27/21 | IMPL | Impel Neuropharma Inc | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 6,750 | 15.00 | 0 | 450 | 19 | 2,760 | D | |||||||||||||||
8/12/20 21:00 | 8/11/20 | CMPI | Checkmate Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 3,000 | 15.00 | 0 | 200 | 6 | 3,673 | D | |||||||||||||||
6/25/19 09:20 | 6/24/19 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 4,000 | 16.00 | 0 | 250 | 7 | 3,955 | I | |||||||||||||||
1/29/18 16:22 | 1/25/18 | MNLO | Menlo Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 4,505 | 17.00 | 0 | 265 | 22 | 1,462 | D | |||||||||||||||
11/13/17 16:27 | 11/13/17 | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund II L.P. | CA | T | P.d | 1,785 | 14.00 | 0 | 128 | 4 | 3,579 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |